Clinical Trials in Cancer 2010 has become the most significant event for those working in oncology in the pharmaceutical sector. This show intends to assemble leading industry professionals and academic experts to discuss in managing clinical development in this crucial therapeutic area. It would also provide them an opportunity to address the contemporary issues and challenges related to translational medicine. This episode will enable the attendees to understand the factors affecting the reduction rates of oncology compounds in clinical trials. They will also get to know about the latest cancer therapies in personalised medicine and the possible use of novel transcriptomic-based biomarkers. The conference will feature case studies from renowned speakers on the logistical and operational issues of conducting clinical trials in Europe.
The targeted visitors at the Clinical Trials in Cancer 2010 are from:
- Medical Directors
- Medical Oncology Executives
- Medical Affairs Executives
- Clinical Operations Executives
- Clinical Trials Executives
- Clinical Research Professionals